A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

764

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

February 2, 2021

Study Completion Date

January 29, 2025

Conditions
Alopecia Areata
Interventions
DRUG

Baricitinib

Administered orally.

DRUG

Placebo

Administered orally.

Trial Locations (75)

3100

RM Pharma Specialists S.A. de C.V., Distrito Federal

13620

Seoul National University Bundang Hospital, Seongnam

14642

University of Rochester School of Medicine, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

17033

Penn State Univ. Milton S. Hershey Medical Center, Hershey

19104

Perelman Center for Advanced Medicine, Philadelphia

19341

Dermatology and Skin Surgery Center, Exton

19462

Dermatology Associates of Plymouth Meeting, Plymouth Meeting

20769

Callender Center for Clinical Research, LLC / Research, Glenn Dale

22332

Inha University Hospital, Jung-gu

29425

Medical University of South Carolina, Charleston

30263

Medaphase Inc, Newnan

31217

Skin Care Physicians of Georgia, Macon

32073

Park Avenue Dermatology, Orange Park

32256

Solutions Through Advanced Research, Inc., Jacksonville

33125

University of Miami, Miami

34000

Instituto de Investigaciones Aplicadas a la Neurociencia A.C, Durango

35015

Chungnam National University Hospital, Daejeon

35233

University of Alabama at Birmingham, Birmingham

36608

Coastal Clinical Research, Inc, Mobile

40241

Forefront Research, Louisville

41944

Kyung Pook National University Hospital, Daegu

43230

OH State Univ College of Med, Gahanna

44106

University Hospitals Cleveland Medical Center, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

44650

Clinica de Investigacion en Reumatologia y Obesidad S. C., Guadalajara

44657

Consultorio Privado de la Dra. Villanueva, Guadalajara

48346

Clarkston Skin Research, Clarkston

49241

Pusan National University Hospital, Busan

54907

Chonbuk National University Hospital, Jeonju

55455

University of Minnesota Medical School, Minneapolis

60611

Northwestern University, Chicago

64060

CRI Centro Regiomontano de Investigacion S.C., Monterrey

64460

Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey

72916

Johnson Dermatology, Fort Smith

75231

Modern Research Associates, Dallas

77004

Center for Clinical Studies, Houston

77401

Bellaire Dermatology, Bellaire

77598

Center for Clinical Studies, Webster

78218

Texas Dermatology and Laser Specialists, San Antonio

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

78660

Austin Institute for Clinical Research, Pflugerville

82140

B&B Investigaciones Medicas, SC, Mazatlán

84107

University of Utah MidValley Dematology, Murray

90045

Dermatology Research Associates, Los Angeles

90403

Mosaic Dermatology, Santa Monica

92024

California Dermatology & Clinical Research Institute, Encinitas

92123

University Clinical Trials, Inc., San Diego

92612

Alliance Research Centers, Irvine

92617

University of CA, Irvine, Irvine

94063

Stanford Health Care, Redwood City

95816

University of California Davis-Dermatology, Sacramento

97210

NW Dermatology & Research Center, LLC, Portland

97223

Oregon Medical Research Center, Portland

97239

OHSU Center for Health and Healing, Portland

98101

Dermatology Associates, Seattle

06519

Yale University School of Medicine, New Haven

33613-1244

ForCare Clinical Research, Tampa

01915

ActivMed Practices and Research, Beverly

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

03801

ActivMed Practices and Research, Portsmouth

10467-2490

Montefiore Medical Center, The Bronx

830 0011

Kurume University Hospital, Kurume

431-3192

Hamamatsu University School of Medicine, University Hospital, Hamamatsu

160-0023

Tokyo Medical Univ. Hospital, Shinjuku-ku

545-8586

Osaka City University Hospital, Osaka

Unknown

Derma Norte del Bajío, S.C., Aguascalientes

00716

Ponce School of Medicine CAIMED Center, Ponce

00917

GCM Medical Group, PSC- Hato Rey, San Juan

03080

Seoul National University Hospital, Seoul

03312

Eunpyeong St. Mary's Hospital, Seoul

05030

Konkuk University Medical Center, Seoul

05278

Kyunghee University Hospital at Gangdong, Seoul

06973

Chungang University Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Incyte Corporation

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT03570749 - A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata | Biotech Hunter | Biotech Hunter